The lawsuit, by the drug-maker Amgen, is looking to overturn a decision by Colorado’s Prescription Drug Affordability Board to cap the price on Enbrel
The lawsuit, by the drug-maker Amgen, is looking to overturn a decision by Colorado’s Prescription Drug Affordability Board to cap the price on Enbrel